SCHEMBL7094438

SCHEMBL7094438

COCCOC(=O)C(Cl)=Cc1cc(-n2ncc(C(F)(F)F)c(C)c2=O)ccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 10/20 0.35
MCHR1 Q99705 8/20 0.35
NOTUM Q6P988 1/20 0.35
CCR1 P32246 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
TRPC3 Q13507 1/20 0.33
ALDH1A1 P00352 3/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
KMT2A Q03164 2/20 0.32
PAX8 Q06710 2/20 0.32
S1PR4 O95977 1/20 0.32
MAPT P10636 1/20 0.32
S1PR1 P21453 1/20 0.32
HTT P42858 1/20 0.32
CYP1A2 P05177 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094437 1.00 NPBWR1 (0.35) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7093687 0.91 ALDH1A1 (0.38) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7018209 0.91 ALDH1A1 (0.38) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7092596 0.90 NPBWR1 (0.32) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7092597 0.90 NPBWR1 (0.32) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7092603 0.89 NPBWR1 (0.38) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7023491 0.89 NPBWR1 (0.38) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7095595 0.89 NPBWR1 (0.32) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7095596 0.89 NPBWR1 (0.32) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2
SCHEMBL7018601 0.88 NPC1 (0.34) NPBWR1MCHR1NOTUMCCR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130123-A1 2-Phenyl-2h-pyridazine-3-ones BASF AKTIENGESELLSCHAFT (DE) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130123-A1 2-Phenyl-2h-pyridazine-3-ones CNPY2, CBR3, CBR1 NPBWR1 371/4885MCHR1 1187/4885NOTUM 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.